Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 3, 2007 - Issue 2
Submit an article Journal homepage
90
Views
6
CrossRef citations to date
0
Altmetric
Expert Opinion

Role of pregabalin in the treatment of generalized anxiety disorder

David S Baldwin1 Clinical Neuroscience Division, University of Southampton, UK;2 Mood Disorders Service, Hampshire Partnership NHS Trust, Southampton, UKCorrespondence[email protected]
&
Khalil Ajel1 Clinical Neuroscience Division, University of Southampton, UK;2 Mood Disorders Service, Hampshire Partnership NHS Trust, Southampton, UK
Pages 185-191 | Published online: 25 Nov 2022

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Michelle Nigri Levitan, Marcelo Papelbaum & Antonio Egidio Nardi. (2015) Profile of agomelatine and its potential in the treatment of generalized anxiety disorder. Neuropsychiatric Disease and Treatment 11, pages 1149-1155.
Read now
Jennifer A Reinhold & Karl Rickels. (2015) Pharmacological treatment for generalized anxiety disorder in adults: an update. Expert Opinion on Pharmacotherapy 16:11, pages 1669-1681.
Read now
David S Baldwin, Khalil Ajel, Vasilios G Masdrakis, Magda Nowak & Rizwan Rafiq. (2013) Pregabalin for the treatment of generalized anxiety disorder: an update. Neuropsychiatric Disease and Treatment 9, pages 883-892.
Read now
Cristina Dobrea, Massimiliano Buoli, Chiara Arici, Giulia Camuri, Bernardo Dell'Osso & Alfredo Carlo Altamura. (2012) Tolerability and use in co-administration of pregabalin in affective patients: a 6-month prospective naturalistic study. Expert Opinion on Drug Safety 11:6, pages 893-899.
Read now
Nastassja Koen & Dan J. Stein. (2011) Pharmacotherapy of anxiety disorders: a critical review. Dialogues in Clinical Neuroscience 13:4, pages 423-437.
Read now
Roger M Pinder. (2007) Treatment of generalized anxiety disorder. Neuropsychiatric Disease and Treatment 3:2, pages 183-184.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.